Purpose of this Study
If you join the study, you will sign a consent form, complete a questionnaire, and provide a blood sample. You will also have your regular low-dose CT scan for lung cancer screening as part of your usual medical care. The study team will review your medical records and follow your health for about 2 years.
Who Can Participate?
Eligibility
People may be able to join this study if they are between 50 and 80 years old and are current or former cigarette smokers with a long history of smoking. They must already be scheduled to have a special lung scan called a low dose CT scan to check for lung cancer. Participants need to be able to understand the study and agree to take part.
People cannot join if they are currently being treated for cancer, have had a cancer diagnosis within the past five years except for certain skin cancers, or have symptoms that could suggest lung cancer. Researchers are studying ways to learn more about lung health and lung cancer screening in people at higher risk for lung cancer.
Age Range
50-80
Sex/Genders
Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
Yes
What is Involved?
Description
This study is testing a new blood test called FMBT-Lung to see how well it can help find lung cancer in people who are already getting routine lung cancer screening. Researchers hope this blood test may improve the early detection of lung cancer and help support future screening methods.
Locations
Pickett Road Research
Other
Visit Timing
Weekdays
Weekends
Evenings
Compensation
Yes
Spanish Materials Available
No
Study Details
Full Title
The PROACT LUNG Study: A Prospective Observational Clinical Validation Study of the Freenome Multiomics Blood Test for Lung Cancer Screening
Principal Investigator
James
Davis
Protocol Number
PRO00120074
NCT ID
NCT06122077
Enrollment Status
Pending Open to Enrollment